<DOC>
	<DOCNO>NCT00744263</DOCNO>
	<brief_summary>The purpose study assess efficacy 13-valent pneumococcal conjugate vaccine prevention first episode vaccine-type pneumococcal community-acquired pneumonia adult .</brief_summary>
	<brief_title>Study Evaluating Effiacy 13-Valent Pneumococcal Conjugate Vaccine ( 13vPnC ) Adults</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Pneumonia , Pneumococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male female adult age 65 year old day vaccination able fulfill study requirement . Previous vaccination license experimental pneumococcal vaccine Residence nursing home , longterm care facility , similar facility Known hypersensitivity vaccination Immune deficiency suppression</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>